# China Pharma Holdings, Inc.: Form 10-Q/A for the period ended Jun 30, 2011

- Company: [China Pharma Holdings, Inc.](/companies/cphi.md) (CIK 1106644)
- Form: 10-Q/A
- Filed: 2011-09-06
- Accepted by EDGAR: Sep 6, 2011, 16:51 ET
- Period: 2011-06-30
- Accession: 0001010549-11-000997
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1106644/000101054911000997/cphi10qa063011.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1106644/000101054911000997/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2011-06-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2011-04-01 to 2011-06-30 | $19.6m | us-gaap:Revenues |
| Revenue | 6 months, 2011-01-01 to 2011-06-30 | $37.7m | us-gaap:Revenues |
| Cost of revenue | 3 months, 2011-04-01 to 2011-06-30 | $12.3m | us-gaap:CostOfRevenue |
| Cost of revenue | 6 months, 2011-01-01 to 2011-06-30 | $23.6m | us-gaap:CostOfRevenue |
| Gross profit | 3 months, 2011-04-01 to 2011-06-30 | $7.3m | us-gaap:GrossProfit |
| Gross profit | 6 months, 2011-01-01 to 2011-06-30 | $14.2m | us-gaap:GrossProfit |
| Operating income | 3 months, 2011-04-01 to 2011-06-30 | $5.8m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months, 2011-01-01 to 2011-06-30 | $11.1m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months, 2011-04-01 to 2011-06-30 | −$61.2k | us-gaap:InterestExpense |
| Interest expense | 6 months, 2011-01-01 to 2011-06-30 | −$122.4k | us-gaap:InterestExpense |
| Income tax | 3 months, 2011-04-01 to 2011-06-30 | −$888.9k | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months, 2011-01-01 to 2011-06-30 | −$1.7m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2011-04-01 to 2011-06-30 | $5.1m | us-gaap:NetIncomeLoss |
| Net income | 6 months, 2011-01-01 to 2011-06-30 | $10.2m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2011-04-01 to 2011-06-30 | $0.12 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months, 2011-01-01 to 2011-06-30 | $0.23 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2011-04-01 to 2011-06-30 | $0.12 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months, 2011-01-01 to 2011-06-30 | $0.23 | us-gaap:EarningsPerShareBasic |
| Operating cash flow | 6 months, 2011-01-01 to 2011-06-30 | $3.6m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months, 2011-01-01 to 2011-06-30 | −$223.8k | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | at 2011-06-30 | $4.7m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2011-06-30 | $101.0m | us-gaap:AssetsCurrent |
| Total assets | at 2011-06-30 | $143.4m | us-gaap:Assets |
| Current liabilities | at 2011-06-30 | $12.3m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2011-06-30 | $12.4m | us-gaap:Liabilities |
| Shareholders' equity | at 2011-06-30 | $131.0m | us-gaap:StockholdersEquity |

## Sections

No standard item headings were found in this filing’s main document, so no sections were extracted. Read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/1106644/000101054911000997/cphi10qa063011.htm

Filed Sep 6, 2011.
Source: SEC EDGAR, the filing index for accession 0001010549-11-000997. Last ingested by Listed: Nov 11, 2026, 00:23 ET. No prices; not investment advice.